Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$71.24 - $85.35 $13,749 - $16,472
193 Added 4.62%
4,368 $372,000
Q4 2023

Feb 05, 2024

SELL
$80.59 - $92.61 $10,234 - $11,761
-127 Reduced 2.95%
4,175 $357,000
Q3 2023

Nov 07, 2023

SELL
$82.56 - $93.49 $55,975 - $63,386
-678 Reduced 13.61%
4,302 $385,000
Q2 2023

Aug 04, 2023

SELL
$80.84 - $89.45 $77,768 - $86,050
-962 Reduced 16.19%
4,980 $423,000
Q1 2023

May 08, 2023

BUY
$72.75 - $90.6 $432,280 - $538,345
5,942 New
5,942 $491,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.02B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.